[Corrigendum] MicroRNA‑497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl‑2.

导出 OA

翻译打印收藏纠错

第一作者： Faqing,Tian

第一单位： Department of Hematology, Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong 518172, P.R. China.

作者： Faqing,Tian ^[1] ; Yong,Zhan ^[2] ; Wei,Zhu ^[3] ; Juheng,Li ^[1] ; Meiqin,Tang ^[1] ; Xiaohui,Chen ^[1] ; Jian,Jiang ^[1]

作者单位： Department of Hematology, Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong 518172, P.R. China. ^[1] Department of Radiology, Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong 518172, P.R. China. ^[2] Department of Pathology, School of Basic Medicine, Guangdong Medical University, Dongguan, Guangdong 523808, P.R. China. ^[3]

DOI 10.3892/ijmm.2019.4297

PMID 31432126

发布时间 2020-02-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

International journal of molecular medicine

2019年44卷4期

1594页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

[Corrigendum] MicroRNA‑497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl‑2.

International journal of molecular medicine

相似文献

International journal of molecular medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

[Corrigendum] MicroRNA‑497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl‑2.

International journal of molecular medicine

相似文献

International journal of molecular medicine

相关期刊

检索历史清除